Summary
- Current Price
- As of today, ORMP price is $4.78, up +4.60% on
- Current Price All-Time High
- ORMP price is currently -84.94% below its historical high of $31.73 set on
- Market Cap
- ORMP current market cap is $199M, up +136.31% over the past 365 days
- PE Ratio
- ORMP current PE ratio is 1.16
- Revenue
- ORMP current annual revenue is $2.00M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for ORMP is on
Profile
| Metric | Value |
|---|---|
| Full Name | Oramed Pharmaceuticals Inc. |
| Ticker | NASDAQ: ORMP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | oramed.com |
| Employees | 13 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $4.78 | ||
| Price, 1D Change | +4.60% | |
| $199M | ||
| 5.23% | ||
| 1.16 | ||
| 1.15 | ||
| $2.00M | ||
| Revenue, 1Y Change | +100.00% | |
| $1.50 | ||
| EPS, 1Y Change | +421.21% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.25 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $1.50 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $2.00M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $4.78 | ||
| Price Target | $6.25 | - |
| Price Tgt. Change | +30.75% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.14 | - | |
| - | -$0.47 | - | |
| - | $1.50 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $1.34M | - | |
| - | $0.00 | - | |
| - | $2.00M | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +132.04% | ||
| +47.53% | ||
| +136.31% | ||
| +52.59% | ||
| +100.00% | ||
| -26.01% | ||
| +421.21% | ||
| +259.94% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $4.78 | ||
| $3.57 | ||
| $4.20 | ||
| $3.64 | ||
| $4.21 | ||
| $0.11 | ||
| 1.15 | ||
| $0.21 | ||
| 68.41 | ||
| 37.04% |
Dividends
| Metric | Value | Date |
|---|---|---|
| $0.25 | ||
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $2.00M | ||
| $1.50 | ||
| $13.00K | ||
| 0.65% | ||
| -$15.09M | ||
| -754.40% | ||
| $63.21M | ||
| - | ||
| -$14.97M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 6.98 | ||
| 6.98 | ||
| - | ||
| - | ||
| 3.47 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 1.16 | ||
| - | ||
| 0.63 | ||
| -10.34 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $199.74M | ||
| $125.89M | ||
| $230.86M | ||
| $133.27M | ||
| $31.12M | ||
| $19.09M | ||
| $825.00K | ||
| $285.00K | ||
| $443.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| -$61.24M | ||
| $15.10M | ||
| $1.99M | ||
| $0.00 | ||
| $121.00K | ||
| $0.00 | ||
| $11.31M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$9.15M | ||
| $5.44M | ||
| -$4.74M | ||
| $9,000.00 | ||
| -$9.15M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Aegis Capital | ||
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| Aegis Capital |
Analyst sentiment
Institutional ownership
Screeners with ORMP
FAQ
- What is the ticker symbol for Oramed Pharmaceuticals Inc.?
- The ticker symbol for Oramed Pharmaceuticals Inc. is NASDAQ:ORMP
- Does Oramed Pharmaceuticals Inc. pay dividends?
- Yes, Oramed Pharmaceuticals Inc. pays dividends. The last payment was $0.25, with an ex-dividend date on January 16, 2026
- What sector is Oramed Pharmaceuticals Inc. in?
- Oramed Pharmaceuticals Inc. is in the Healthcare sector
- What industry is Oramed Pharmaceuticals Inc. in?
- Oramed Pharmaceuticals Inc. is in the Biotechnology industry
- What country is Oramed Pharmaceuticals Inc. based in?
- Oramed Pharmaceuticals Inc. is headquartered in United States
- When did Oramed Pharmaceuticals Inc. go public?
- Oramed Pharmaceuticals Inc. initial public offering (IPO) was on May 1, 2007
- Is Oramed Pharmaceuticals Inc. in the S&P 500?
- No, Oramed Pharmaceuticals Inc. is not included in the S&P 500 index
- Is Oramed Pharmaceuticals Inc. in the NASDAQ 100?
- No, Oramed Pharmaceuticals Inc. is not included in the NASDAQ 100 index
- Is Oramed Pharmaceuticals Inc. in the Dow Jones?
- No, Oramed Pharmaceuticals Inc. is not included in the Dow Jones index
- When was Oramed Pharmaceuticals Inc. last earnings report?
- Oramed Pharmaceuticals Inc.'s most recent earnings report was on August 10, 2026
- When does Oramed Pharmaceuticals Inc. report earnings?
- The next expected earnings date for Oramed Pharmaceuticals Inc. is November 12, 2026
Data Sources & References
- ORMP Official Website www.oramed.com
- ORMP Profile on Yahoo Finance finance.yahoo.com/quote/ORMP
- ORMP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ormp